Zobrazeno 1 - 10
of 47
pro vyhledávání: ''
Autor:
Tigris Study Investigators, Christopher B. Granger, Katarina Hedman, Richard Grieve, Satoshi Yasuda, Kirsten L. Rennie, Shaun G. Goodman, John Gregson, Mauricio G. Cohen, Ji Y Chen, Dirk Westermann, Tabassome Simon, Karolina Andersson Sundell, Stuart J. Pocock, David Brieger, Jose C. Nicolau
Publikováno v:
Clinical Cardiology
Clinical Cardiology, Wiley, In press, ⟨10.1002/clc.23283⟩
Clinical Cardiology, Wiley, In press, ⟨10.1002/clc.23283⟩
International audience; Background: Risk prediction tools are lacking for patients with stable disease some years after myocardial infarction (MI).Hypothesis: A practical long‐term cardiovascular risk index can be developed.Methods: The long‐Term
Autor:
Aviral Vij, Hitesh Chawla, Kameel Kassab, Neeraj Jolly, Amandeep Kaur, Vamsi Kodumuri, Rami Doukky
Publikováno v:
Clinical Cardiology
Background Heart disease remains the leading cause of death in the United States. Although there are clear indications for revascularization in patients with acute coronary syndromes, there is debate regarding the benefits of revascularization in sta
Autor:
Alain Leguerrier, Didier Carrié, Patrick Donzeau-Gouge, Thierry Lefèvre, Stephan Chassaing, Etienne Puymirat, Jean Fajadet, Martine Gillard, Emmanuel Teiger, Pascal Leprince, Hervé Le Breton, Michel Lievre, Eric Durand, Jean-Philippe Collet, Dominique Himbert, Didier Tchetche, Karine Chevreul, Bernard Lung, Hélène Eltchaninoff, Romain Didier, Florence Leclercq, Didier Blanchard
Publikováno v:
Clinical Cardiology
Clinical Cardiology, Wiley, 2017, 40 (12), pp.1316-1322. ⟨10.1002/clc.22830⟩
Clinical Cardiology, 2017, 40 (12), pp.1316-1322. ⟨10.1002/clc.22830⟩
Clinical Cardiology, Wiley, 2017, 40 (12), pp.1316-1322. ⟨10.1002/clc.22830⟩
Clinical Cardiology, 2017, 40 (12), pp.1316-1322. ⟨10.1002/clc.22830⟩
BACKGROUND: Coronary artery disease (CAD) is common in patients undergoing transcatheter aortic valve replacement (TAVR). However, the impact of CAD distribution before TAVR on short‐ and long‐term prognosis remains unclear. HYPOTHESIS: We hypoth
Autor:
Chun Chih Chiu, Hsin Ban Leu, Ting Yung Chang, Ruey Hsing Chou, Chin Chou Huang, Hsin Lei Huang, Chien Yi Hsu, Jaw Wen Chen, Po Hsun Huang, Shing Jong Lin
Publikováno v:
Clinical Cardiology. 40:697-703
BACKGROUND: Epicardial adipose tissue is associated with coronary artery disease (CAD). Circulating endothelial progenitor cell (EPC) level represents a marker of endothelial dysfunction and vascular health. However, the relationship between epicardi
Publikováno v:
Clinical Cardiology
Despite reducing progression and promoting regression of coronary atherosclerosis, statin therapy does not fully address residual cardiovascular (CV) risk. High-purity eicosapentaenoic acid (EPA) added to a statin has been shown to reduce CV events a
Autor:
Larry E. Fields, Zhong Yuan, Sally Tamayo, Nicholas Sicignano, Kathleen Hopf, Troy C. Sarich, Daniel Yannicelli, W. Frank Peacock, Shujian Wu, Manesh R. Patel
Publikováno v:
Clinical Cardiology
Background In nonvalvular atrial fibrillation (NVAF), rivaroxaban is used to prevent stroke and systemic embolism. Objective To evaluate major bleeding (MB) in NVAF patients treated with rivaroxaban in a real-world clinical setting. Methods From Janu
Autor:
Lohit Garg, Sahil Agrawal, Philip Carson, Raman Dusaj, Anthony A. Bavry, Nainesh Patel, Brijesh Patel, DO Bruce Feldman, Shilpkumar Arora, Susan Steigerwalt, Manyoo Agarwal, Mahek Shah
Publikováno v:
Clinical cardiology. 40(12)
Background Chronic kidney disease (CKD) is a well-known risk factor for coronary artery disease and is associated with poor outcomes following an acute coronary syndrome (NSTE-ACS). The optimal timing of an invasive strategy in patients with CKD and
Autor:
Pasi P. Karjalainen, Marco Proietti, Wail Nammas, Andrea Rubboli, K.E. Juhani Airaksinen, Aissa Bah, Gregory Y.H. Lip, Juha Hartikainen, Heli Lahtela, Axel Schlitt, Tuomas Kiviniemi
Publikováno v:
Lahtela, H M, Bah, A, Kiviniemi, T, Nammas, W, Schlitt, A, Rubboli, A, Karjalainen, P P, Proietti, M, Hartikainen, J E K, Lip, G Y H & Airaksinen, K E J 2017, ' Outcome of octogenarians with atrial fibrillation undergoing percutaneous coronary intervention : insights from the AFCAS registry ', Clinical Cardiology, vol. 40, no. 12, pp. 1264-1270 . https://doi.org/10.1002/clc.22821
BACKGROUND: More evidence is needed on the optimal antithrombotic regimen in elderly patients with atrial fibrillation (AF) undergoing percutaneous coronary intervention (PCI).HYPOTHESIS: Octogenarian patients (aged ≥80 years) with AF who underwent
Autor:
Itay Rabinovich, Shmuel Banai, Yaron Arbel, Gad Keren, Itzhak Herz, Hezzy Shmueli, Ofer Havakuk, Yacov Shacham, Amir Halkin, Ariel Finkelstein, Itzhak Shapira, Shlomo Berliner
Publikováno v:
Clinical Cardiology. 37:479-484
Background An increased serum glucose level in patients with acute coronary syndrome (ACS) is associated with adverse clinical outcome. This hyperglycemia has been attributed, at least in part, to acute stress reaction. Our objective was to determine
Publikováno v:
Clinical Cardiology. 37:395-401
Background Elevated cardiac troponin I (cTnI) occurs in acute coronary syndrome (ACS) as well as various scenarios not associated with ACS. Hypothesis Simple clinical criteria can reliably exclude ACS among hospitalized patients with elevated cTnI. M